Literature DB >> 26813759

Co-occurrence of MYC amplification and TP53 mutations in human cancer.

Peter Ulz1, Ellen Heitzer1, Michael R Speicher1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26813759     DOI： 10.1038/ng.3468

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  10 in total

Review 1.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

2.  Mutual exclusivity analysis identifies oncogenic network modules.

Authors:  Giovanni Ciriello; Ethan Cerami; Chris Sander; Nikolaus Schultz
Journal:  Genome Res       Date:  2011-09-09       Impact factor: 9.043

Review 3.  Taming of the beast: shaping Myc-dependent amplification.

Authors:  Elmar Wolf; Charles Y Lin; Martin Eilers; David L Levens
Journal:  Trends Cell Biol       Date:  2014-12-01       Impact factor: 20.808

Review 4.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

5.  Mediation of c-Myc-induced apoptosis by p53.

Authors:  H Hermeking; D Eick
Journal:  Science       Date:  1994-09-30       Impact factor: 47.728

6.  TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis.

Authors:  Anna Stengel; Susanne Schnittger; Sandra Weissmann; Sabrina Kuznia; Wolfgang Kern; Alexander Kohlmann; Torsten Haferlach; Claudia Haferlach
Journal:  Blood       Date:  2014-05-14       Impact factor: 22.113

7.  Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.

Authors:  Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Jason R Dobson; Jonathan V Eldridge; Jacob L Thomas; Alexandra Papoutsaki; Younhun Kim; Beifang Niu; Michael McLellan; Michael S Lawrence; Abel Gonzalez-Perez; David Tamborero; Yuwei Cheng; Gregory A Ryslik; Nuria Lopez-Bigas; Gad Getz; Li Ding; Benjamin J Raphael
Journal:  Nat Genet       Date:  2014-12-15       Impact factor: 38.330

8.  Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.

Authors:  Rebecca M Hill; Sanne Kuijper; Janet C Lindsey; Kevin Petrie; Ed C Schwalbe; Karen Barker; Jessica K R Boult; Daniel Williamson; Zai Ahmad; Albert Hallsworth; Sarra L Ryan; Evon Poon; Simon P Robinson; Ruth Ruddle; Florence I Raynaud; Louise Howell; Colin Kwok; Abhijit Joshi; Sarah Leigh Nicholson; Stephen Crosier; David W Ellison; Stephen B Wharton; Keith Robson; Antony Michalski; Darren Hargrave; Thomas S Jacques; Barry Pizer; Simon Bailey; Fredrik J Swartling; William A Weiss; Louis Chesler; Steven C Clifford
Journal:  Cancer Cell       Date:  2014-12-18       Impact factor: 31.743

9.  The landscape of somatic copy-number alteration across human cancers.

Authors:  Rameen Beroukhim; Craig H Mermel; Dale Porter; Guo Wei; Soumya Raychaudhuri; Jerry Donovan; Jordi Barretina; Jesse S Boehm; Jennifer Dobson; Mitsuyoshi Urashima; Kevin T Mc Henry; Reid M Pinchback; Azra H Ligon; Yoon-Jae Cho; Leila Haery; Heidi Greulich; Michael Reich; Wendy Winckler; Michael S Lawrence; Barbara A Weir; Kumiko E Tanaka; Derek Y Chiang; Adam J Bass; Alice Loo; Carter Hoffman; John Prensner; Ted Liefeld; Qing Gao; Derek Yecies; Sabina Signoretti; Elizabeth Maher; Frederic J Kaye; Hidefumi Sasaki; Joel E Tepper; Jonathan A Fletcher; Josep Tabernero; José Baselga; Ming-Sound Tsao; Francesca Demichelis; Mark A Rubin; Pasi A Janne; Mark J Daly; Carmelo Nucera; Ross L Levine; Benjamin L Ebert; Stacey Gabriel; Anil K Rustgi; Cristina R Antonescu; Marc Ladanyi; Anthony Letai; Levi A Garraway; Massimo Loda; David G Beer; Lawrence D True; Aikou Okamoto; Scott L Pomeroy; Samuel Singer; Todd R Golub; Eric S Lander; Gad Getz; William R Sellers; Matthew Meyerson
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

10.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962
  10 in total
  21 in total

1.  A time-series analysis of altered histone H3 acetylation and gene expression during the course of MMAIII-induced malignant transformation of urinary bladder cells.

Authors:  Jinqiu Zhu; Jie Wang; Xushen Chen; Maria Tsompana; Daniel Gaile; Michael Buck; Xuefeng Ren
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

2.  Cooperative genomic alteration network reveals molecular classification across 12 major cancer types.

Authors:  Hongyi Zhang; Yulan Deng; Yong Zhang; Yanyan Ping; Hongying Zhao; Lin Pang; Xinxin Zhang; Li Wang; Chaohan Xu; Yun Xiao; Xia Li
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

3.  The molecular basis of breast cancer pathological phenotypes.

Authors:  Yujing J Heng; Susan C Lester; Gary Mk Tse; Rachel E Factor; Kimberly H Allison; Laura C Collins; Yunn-Yi Chen; Kristin C Jensen; Nicole B Johnson; Jong Cheol Jeong; Rahi Punjabi; Sandra J Shin; Kamaljeet Singh; Gregor Krings; David A Eberhard; Puay Hoon Tan; Konstanty Korski; Frederic M Waldman; David A Gutman; Melinda Sanders; Jorge S Reis-Filho; Sydney R Flanagan; Deena Ma Gendoo; Gregory M Chen; Benjamin Haibe-Kains; Giovanni Ciriello; Katherine A Hoadley; Charles M Perou; Andrew H Beck
Journal:  J Pathol       Date:  2016-12-29       Impact factor: 7.996

4.  Inferring expressed genes by whole-genome sequencing of plasma DNA.

Authors:  Peter Ulz; Gerhard G Thallinger; Martina Auer; Ricarda Graf; Karl Kashofer; Stephan W Jahn; Luca Abete; Gunda Pristauz; Edgar Petru; Jochen B Geigl; Ellen Heitzer; Michael R Speicher
Journal:  Nat Genet       Date:  2016-08-29       Impact factor: 38.330

5.  A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence.

Authors:  Sander Canisius; John W M Martens; Lodewyk F A Wessels
Journal:  Genome Biol       Date:  2016-12-16       Impact factor: 13.583

Review 6.  MYC Deregulation in Primary Human Cancers.

Authors:  Manpreet Kalkat; Jason De Melo; Katherine Ashley Hickman; Corey Lourenco; Cornelia Redel; Diana Resetca; Aaliya Tamachi; William B Tu; Linda Z Penn
Journal:  Genes (Basel)       Date:  2017-05-25       Impact factor: 4.096

7.  Identification of outcome-related driver mutations in cancer using conditional co-occurrence distributions.

Authors:  Victor Treviño; Emmanuel Martínez-Ledesma; José Tamez-Peña
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

8.  Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.

Authors:  Jelena Belic; Ricarda Graf; Thomas Bauernhofer; Yauheniya Cherkas; Peter Ulz; Julie Waldispuehl-Geigl; Samantha Perakis; Michael Gormley; Jaymala Patel; Weimin Li; Jochen B Geigl; Denis Smirnov; Ellen Heitzer; Mitchell Gross; Michael R Speicher
Journal:  Int J Cancer       Date:  2018-04-10       Impact factor: 7.396

9.  Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.

Authors:  Peter Ulz; Jelena Belic; Ricarda Graf; Martina Auer; Ingrid Lafer; Katja Fischereder; Gerald Webersinke; Karl Pummer; Herbert Augustin; Martin Pichler; Gerald Hoefler; Thomas Bauernhofer; Jochen B Geigl; Ellen Heitzer; Michael R Speicher
Journal:  Nat Commun       Date:  2016-06-22       Impact factor: 17.694

10.  BeWith: A Between-Within method to discover relationships between cancer modules via integrated analysis of mutual exclusivity, co-occurrence and functional interactions.

Authors:  Phuong Dao; Yoo-Ah Kim; Damian Wojtowicz; Sanna Madan; Roded Sharan; Teresa M Przytycka
Journal:  PLoS Comput Biol       Date:  2017-10-12       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.